A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer Dr. Nandita Mohan31 May 2022 9:15 AM ISTA study in European Urology examined whether men at an increased genetic risk of prostate cancer can offset their risk of disease or disease...
New combined therapy helps extend lives of men with prostate cancer Dr. Kamal Kant Kohli29 May 2022 7:30 PM ISTPractice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy-a commonly used hormone injection-plus...
Obese Smokers at higher risk of dying from prostate cancer: Study Medical Dialogues Editorial Team27 May 2022 8:00 PM ISTSweden: The reduced prostate cancer (PCa) risk for smokers throughout the PSA era, especially for low-risk PCa, is most likely due to smokers' low...
Addition of androgen deprivation therapy to PBRT halts progression of prostate cancer: Lancet Medical Dialogues Editorial Team24 May 2022 9:30 AM ISTA new study published in The Lancet shows the advantage of combining short-term androgen deprivation treatment (ADT) with prostate bed radiation...
Glenmark Pharma bags USFDA nod for prostate cancer drug Abiraterone Acetate Ruchika Sharma20 May 2022 12:15 PM ISTProstate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate.
Myovant Sciences, Accord Healthcare ink pact for prostate cancer treatment Relugolix Ruchika Sharma10 May 2022 10:15 AM ISTORGOVYX (relugolix, 120 mg) is indicated in Europe for the treatment of adult patients with advanced hormone-sensitive prostate cancer.
Researchers look to licorice for promising treatment of prostate cancer Dr. Kamal Kant Kohli7 May 2022 9:00 AM ISTLicorice is more than a candy people either love or hate-it may play a role in preventing or treating certain types of cancer, according to...
Bayer gets USFDA priority review for darolutamide plus docetaxel to treat metastatic hormone-sensitive prostate cancer Ruchika Sharma4 May 2022 12:00 PM ISTDarolutamide is developed jointly by Bayer and Orion Corporation, a globally operating Finnish pharmaceutical company.
Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases Dr. Kamal Kant Kohli28 April 2022 9:00 AM ISTOver the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to...
Long term insomnia associated with incident Prostate cancer Medical Dialogues Editorial Team26 April 2022 9:00 AM ISTIn a new study conducted by Xiaoyan Lv and and team it was shown that having a relatively easy time getting out of bed in the morning and frequently...
DXA screening may help prevent fractures among older men with prostate cancer: JAMA Dr. Shravani Dali22 April 2022 6:15 AM ISTAndrogen deprivation therapy (ADT) negatively impacts bone health and results in decreased bone mineral density and fractures, finds a new study....
Androgen deprivation therapy in men with prostate cancer reduces risk of thyroid diseases: Study Medha Baranwal18 April 2022 9:00 AM ISTTaiwan: The use of androgen deprivation therapy (ADT) in men with metastatic prostate cancer (PCa) is tied to a reduced risk of thyroid disease...
